MC
NDRM

Menta Capital’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Menta Capital’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,500
Closed -$344K – 953
2017
Q2 		$344K Sell
11,500
-13,376
-54% -$346K 0.04% 628
2017
Q1 		$660K Sell
24,876
-86,020
-78% -$2.13M 0.06% 481
2016
Q4 		$2.46M Sell
110,896
-800
-0.7% -$15K 0.21% 130
2016
Q3 		$2.06M Buy
111,696
+912
+0.8% +$15.8K 0.2% 166
2016
Q2 		$1.8M Buy
110,784
+14,860
+15% +$250K 0.25% 82
2016
Q1 		$1.35M Buy
95,924
+48,453
+102% +$655K 0.19% 116
2015
Q4 		$809K Buy
47,471
+29,161
+159% +$568K 0.1% 331
2015
Q3 		$378K Buy
+18,310
New +$376K 0.06% 509

Other funds holding NDRM

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Menta Capital's NDRM Position: Q3 2017 in Review

Menta Capital sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 11,500 shares — an estimated $344K sold.

Menta Capital first reported a position in NDRM in Q3 2015 and held it in 8 quarters. The position peaked at $2.46M in Q4 2016. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

  • Menta Capital reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Menta Capital sold 11,500 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $344K.
  • Menta Capital first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 8 quarters.
  • Menta Capital's NeuroDerm Ltd. Ordinary Shares position peaked at $2.46M in Q4 2016.
  • 81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Menta Capital's 13F filing for Q3 2017, filed 14 Nov 2017.